SS
Shravan Solanki
About Shravan Solanki
Data last updated:
Shravan Solanki is a Director at Vaxa India Private Limited (since 2018). The companies operate in Business Services. Vaxa India Private Limited reported revenue of ₹1.1 Lakh (FY 2019). Earlier, Shravan Solanki was a Director at Flyvaxa Private Limited (from 2020) and Director at Best Kind Multitrade Private Limited (from 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Feb 2018 | 2018 | ₹1.1 Lakh (FY 2019) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Jun 2020 | 2020 | Strike Off | ||
| Director | 13 Oct 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shravan Solanki
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Kumar Bhardwaj | 07723636 | Vaxa India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shravan Solanki
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shravan Solanki
Shravan Solanki currently holds 1 directorship: Vaxa India Private Limited (Director, since 22 Feb 2018, revenue ₹1.1 Lakh (FY 2019)).
Shravan Solanki was first appointed on 22 Feb 2018 as Director at Vaxa India Private Limited. The most recent appointment on record is 13 Oct 2020 at Best Kind Multitrade Private Limited.
Shravan Solanki held 2 earlier board appointments: Flyvaxa Private Limited (Director, from 03 Jun 2020); Best Kind Multitrade Private Limited (Director, from 13 Oct 2020).
The current boards of Shravan Solanki's companies include Ajay Kumar Bhardwaj (Vaxa India Private Limited).